164 related articles for article (PubMed ID: 11773597)
1. Identification of AKT-regulated genes in inducible MERAkt cells.
Kuhn I; Bartholdi MF; Salamon H; Feldman RI; Roth RA; Johnson PH
Physiol Genomics; 2001 Dec; 7(2):105-14. PubMed ID: 11773597
[TBL] [Abstract][Full Text] [Related]
2. Diosgenin induces hypoxia-inducible factor-1 activation and angiogenesis through estrogen receptor-related phosphatidylinositol 3-kinase/Akt and p38 mitogen-activated protein kinase pathways in osteoblasts.
Yen ML; Su JL; Chien CL; Tseng KW; Yang CY; Chen WF; Chang CC; Kuo ML
Mol Pharmacol; 2005 Oct; 68(4):1061-73. PubMed ID: 15998873
[TBL] [Abstract][Full Text] [Related]
3. Synergy between truncated c-Met (cyto-Met) and c-Myc in liver oncogenesis: importance of TGF-beta signalling in the control of liver homeostasis and transformation.
Amicone L; Terradillos O; Calvo L; Costabile B; Cicchini C; Della Rocca C; Lozupone F; Piacentini M; Buendia MA; Tripodi M
Oncogene; 2002 Feb; 21(9):1335-45. PubMed ID: 11857077
[TBL] [Abstract][Full Text] [Related]
4. Expression of an ATP binding mutant of PKC-delta inhibits Sis-induced transformation of NIH3T3 cells.
Li W; Michieli P; Alimandi M; Lorenzi MV; Wu Y; Wang LH; Heidaran MA; Pierce JH
Oncogene; 1996 Aug; 13(4):731-7. PubMed ID: 8761294
[TBL] [Abstract][Full Text] [Related]
5. Involvement of the Akt/mTOR pathway on EGF-induced cell transformation.
Nomura M; He Z; Koyama I; Ma WY; Miyamoto K; Dong Z
Mol Carcinog; 2003 Sep; 38(1):25-32. PubMed ID: 12949840
[TBL] [Abstract][Full Text] [Related]
6. T antigens' role in polyomavirus transformation: c-myc but not c-fos or c-jun expression is a target for middle T.
Rameh LE; Armelin MC
Oncogene; 1991 Jun; 6(6):1049-56. PubMed ID: 1648700
[TBL] [Abstract][Full Text] [Related]
7. Distinct pathways regulate transforming growth factor beta 1-stimulated proto-oncogene and extracellular matrix gene expression.
Howe PH; Cunningham MR; Leof EB
J Cell Physiol; 1990 Jan; 142(1):39-45. PubMed ID: 2153688
[TBL] [Abstract][Full Text] [Related]
8. Mutations of critical amino acids affect the biological and biochemical properties of oncogenic A-Raf and Raf-1.
Bosch E; Cherwinski H; Peterson D; McMahon M
Oncogene; 1997 Aug; 15(9):1021-33. PubMed ID: 9285556
[TBL] [Abstract][Full Text] [Related]
9. Role of c-myc and other genes in interleukin 2 regulated CT6 T lymphocytes and their malignant variants.
Cleveland JL; Rapp UR; Farrar WL
J Immunol; 1987 May; 138(10):3495-504. PubMed ID: 3106484
[TBL] [Abstract][Full Text] [Related]
10. A chicken c-Rel-estrogen receptor chimeric protein shows conditional nuclear localization, DNA binding, transformation and transcriptional activation.
Zurovec M; Petrenko O; Roll R; Enrietto PJ
Oncogene; 1998 Jun; 16(24):3133-42. PubMed ID: 9671392
[TBL] [Abstract][Full Text] [Related]
11. Akt and 14-3-3eta regulate Miz1 to control cell-cycle arrest after DNA damage.
Wanzel M; Kleine-Kohlbrecher D; Herold S; Hock A; Berns K; Park J; Hemmings B; Eilers M
Nat Cell Biol; 2005 Jan; 7(1):30-41. PubMed ID: 15580267
[TBL] [Abstract][Full Text] [Related]
12. Direct control of the Forkhead transcription factor AFX by protein kinase B.
Kops GJ; de Ruiter ND; De Vries-Smits AM; Powell DR; Bos JL; Burgering BM
Nature; 1999 Apr; 398(6728):630-4. PubMed ID: 10217147
[TBL] [Abstract][Full Text] [Related]
13. Inactivation of a c-Myb/estrogen receptor fusion protein in transformed primary cells leads to granulocyte/macrophage differentiation and down regulation of c-kit but not c-myc or cdc2.
Hogg A; Schirm S; Nakagoshi H; Bartley P; Ishii S; Bishop JM; Gonda TJ
Oncogene; 1997 Dec; 15(24):2885-98. PubMed ID: 9416832
[TBL] [Abstract][Full Text] [Related]
14. Transforming activity of the RL-akt gene, a c-akt gene activated by long terminal repeat insertion in murine leukemia RL(male symbol)1 cells.
Tanino M; Matsuo M; Uenaka A; Tsukuda K; Ouchida M; Nakayama E; Shimizu K
Mol Carcinog; 1999 Dec; 26(4):286-97. PubMed ID: 10569805
[TBL] [Abstract][Full Text] [Related]
15. Transformation of mammary epithelial cells by 3-phosphoinositide- dependent protein kinase-1 activates beta-catenin and c-Myc, and down-regulates caveolin-1.
Xie Z; Zeng X; Waldman T; Glazer RI
Cancer Res; 2003 Sep; 63(17):5370-5. PubMed ID: 14500370
[TBL] [Abstract][Full Text] [Related]
16. Transcription factors in normal and neoplastic pituitary tissues.
Lloyd RV; Osamura RY
Microsc Res Tech; 1997 Oct; 39(2):168-81. PubMed ID: 9361268
[TBL] [Abstract][Full Text] [Related]
17. Transcription factor ATF3 partially transforms chick embryo fibroblasts by promoting growth factor-independent proliferation.
Perez S; Vial E; van Dam H; Castellazzi M
Oncogene; 2001 Mar; 20(9):1135-41. PubMed ID: 11314051
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Bcl3 gene expression mediates the anti-proliferative action of estrogen in pituitary lactotrophs in primary culture.
Mitsui T; Ishida M; Izawa M; Kagami Y; Arita J
Mol Cell Endocrinol; 2011 Oct; 345(1-2):68-78. PubMed ID: 21787835
[TBL] [Abstract][Full Text] [Related]
19. A random walk in oncogene space: the quest for targets.
Vogt PK; Aoki M; Bottoli I; Chang HW; Fu S; Hecht A; Iacovoni JS; Jiang BH; Kruse U
Cell Growth Differ; 1999 Dec; 10(12):777-84. PubMed ID: 10616902
[No Abstract] [Full Text] [Related]
20. The EBV early gene product EB2 transforms rodent cells through a signalling pathway involving c-Myc.
Corbo L; Le Roux F; Sergeant A
Oncogene; 1994 Nov; 9(11):3299-304. PubMed ID: 7936654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
